Analysis Of Deletion Mutation In SMN I Gene For Spinal Muscular Atrophy In A Tertiary Care Centre, Kolkata

Main Article Content

Sarnava Roy
Anindita Joardar
Dhrubajyoti Mridha
Atanu Biswas
Subhasis Sarkar

Abstract

The loss of lower motor neurons in the ventral horns of the spinal cord is the hallmark of spinal muscular atrophy (SMA), the second most prevalent autosomal recessive disorder in children. Some genes cause SMA. Among them, the mutation in the SMN1 gene is the most common, especially exon 7 and exon 8. SMN gene has at least one homologous but inverted copy in the chromosome. From newborns to adults, mutations in the SMN1 gene can impact people in a wide spectrum of severity. Types I, II, III, and IV are the four variations of SMA. The SMN2 gene can be found in each cell of certain individuals with SMA types II and III in three or more copies. The condition is less severe because of these numerous copies of the SMN2 gene. In our tertiary center, we have tried to find out the pattern of deletion and type in the patients. We investigated them depending on their clinical manifestation by PCR of exon 7 and exon 8 followed by RFLP with restriction enzymes DraI & DdeI respectively, for molecular diagnosis. Through molecular study, we have confirmed forty patients with deletions in the SMN1 gene. Among them twenty-five cases showed both deletions of exon 7 and exon 8, thirteen cases were detected with exon 7 deletion, and only two cases with deletion of exon 8.The patients with confirmed deletions were divided into three groups: 16 patients with type III, 19 patients with type II, and 5 patients with type I, based on the clinical symptoms and age of onset. It was commonly observed that the majority of the patient who showed both deletions had a severe phenotype, even if there was some overlap between the deletions detected and the type and severity of SMA.

Downloads

Download data is not yet available.

Article Details

How to Cite
Sarnava Roy, Anindita Joardar, Dhrubajyoti Mridha, Atanu Biswas, & Subhasis Sarkar. (2024). Analysis Of Deletion Mutation In SMN I Gene For Spinal Muscular Atrophy In A Tertiary Care Centre, Kolkata. Journal of Advanced Zoology, 45(1), 524–528. https://doi.org/10.53555/jaz.v45i1.4569
Section
Articles
Author Biographies

Sarnava Roy

Neurogenetic Unit, Department of Neurology, Bangur Institute of Neurosciences, Kolkata.

Anindita Joardar

Asst. Professor, Neurogenetic Unit, Department of Neurology, Bangur Institute of Neurosciences, Kolkata.

Dhrubajyoti Mridha

Neurogenetic Unit, Department of Neurology, Bangur Institute of Neurosciences, Kolkata.

Atanu Biswas

Neurogenetic Unit, Department of Neurology, Bangur Institute of Neurosciences, Kolkata.

Subhasis Sarkar

Asst. Professor, Department of Microbiology, School of Life Sciences, Swami Vivekananda University, Barrackpore.

References

Panigrahi I, Kesari A, Phadke SR, Mittal B. Clinical and molecular diagnosis of spinal muscular atrophy. Neurology India. 2002 Apr 1;50(2):117.

Wirth B. An update of the mutation spectrum of the survival motor neuron gene (SMN1) in autosomal recessive spinal muscular atrophy (SMA). Human mutation. 2000 Mar;15(3):228-37.

Lefebvre S, Bürglen L, Reboullet S, Clermont O, Burlet P, Viollet L, Benichou B, Cruaud C, Millasseau P, Zeviani M, Le Paslier D. Identification and characterization of a spinal muscular atrophy-determining gene. Cell. 1995 Jan 13;80(1):155-65.yighyjgjfgnj

Lunn MR, Wang CH. Spinal muscular atrophy. The Lancet. 2008 Jun 21;371(9630):2120-33.

Verhaart IE, Robertson A, Wilson IJ, Aartsma-Rus A, Cameron S, Jones CC, Cook SF, Lochmüller H. Prevalence, incidence and carrier frequency of 5q–linked spinal muscular atrophy–a literature review. Orphanet journal of rare diseases. 2017 Dec;12(1):1-5.

Grotto S, Cuisset JM, Marret S, Drunat S, Faure P, Audebert-Bellanger S, Desguerre I, Flurin V, Grebille AG, Guerrot AM, Journel H. Type 0 spinal muscular atrophy: further delineation of prenatal and postnatal features in 16 patients. Journal of neuromuscular diseases. 2016 Jan 1;3(4):487-95.

Ogino S, Leonard DG, Rennert H, Ewens WJ, Wilson RB. Genetic risk assessment in carrier testing for spinal muscular atrophy. American journal of medical genetics. 2002 Jul 15;110(4):301-7.

Finkel RS, Sejersen T, Mercuri E, Bertini E, Chen K, Crawford TO, Dubowitz V, de Lemus M, Graham R, Davis RH, Iannaccone S. 218th ENMC International Workshop:: Revisiting the consensus on standards of care in SMA Naarden, The Netherlands, 19–21 February 2016. neuromuscular Disorders. 2017 Jun 1;27(6):596-605.

Dastur RS, Gaitonde PS, Khadilkar SV, Udani VP, Nadkarni JJ. Correlation between deletion patterns of SMN and NAIP genes and the clinical features of spinal muscular atrophy in Indian patients. Neurology India. 2006 Jul 1;54(3):255.

Liang YH, Chen XL, Yu ZS, Chen CY, Bi S, Mao LG, Zhou BL, Zhang XN. Deletion analysis of SMN1 and NAIP genes in Southern Chinese children with spinal muscular atrophy. Journal of Zhejiang University SCIENCE B. 2009 Jan;10(1):29-34.

Ibrahim S, Moatter T, Saleem AF. Spinal muscular atrophy: Clinical spectrum and genetic mutations in Pakistani children. Neurology India. 2012 May 1;60(3):294-8.

Mrad R, Dorboz I, Jemaa B, Maazoul F, Trabelsi M, Chaabouni M, Mlaiki B, Miladi N, Hentati F, Chaabouni H. Molecular analysis of the SMN1 and NAIP genes in 60 Tunisian spinal muscular atrophy patients. La TunisieMedicale. 2006 Aug 1;84(8):465-9.

Sifi Y, Sifi K, Boulefkhad A, Abadi N, Bouderda Z, Cheriet R, Magen M, Bonnefont JP, Munnich A, Benlatreche C, Hamri A. Clinical and genetic study of Algerian patients with spinal muscular atrophy. Journal of Neurodegenerative Diseases. 2013;2013.

Most read articles by the same author(s)

1 2 > >>